In IBCs with normal expression or aberrant expression of PIWI proteins, synthetic piRNAs targeting PIWI genes could be potential tools in transcriptional silencing and antibodies targeting PIWI proteins could also constitute another pertinent approach to antagonize cancer cells proliferation at post-transcriptional level [50]. The gene discussed is PIWIL4; the disease is cancer.